BioSeek

San Francisco, United States Founded: 2000 • Age: 26 yrs Acquired By DiscoverX
Provider of drug discovery services

About BioSeek

BioSeek is a Healthcare company based in San Francisco (United States) founded in 2000, and was acquired by DiscoverX in October 2012. Provider of drug discovery services. BioSeek has raised $10 million across 1 funding round from investors including DiscoverX and Amylin. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its competitors include Lucid Scientific, Kiyatec and CytoTronics; 3 of its 3 listed competitors have raised funding.

Company details

BioSeek was founded in 2000 in San Francisco, United States, as a provider of drug discovery services within the biotechnology sector. Human primary cell assays and predictive disease models are applied to support the development of therapeutics and chemicals. The BioMAP platform is utilized, encompassing BioMAP Systems with controlled human cell cultures, a BioMAP Database for reference profiles, and Predictive Analytics to guide development steps.

Key Metrics
  • Total Equity Funding
    $10M (USD)

    in 1 rounds

  • Latest Funding Round
    $10M (USD), Series C

    May 2007

  • Investors
    DiscoverX

    & 1 more

  • Acquired by
    DiscoverX

    (Oct 2012)

Funding Insights of BioSeek

BioSeek has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series C round of $10 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10M
  • Total Rounds 1
  • Last Round Series C β€” $10M
  • First Round $10M

    (May 2007)

  • Investors Count 1

All 1 funding rounds of BioSeek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2007$10MSeries C––
Valuation history

2 investors in total: 2 institutional.

Investors in BioSeek

BioSeek has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include DiscoverX and Amylin.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Peptide hormone analogues to treat metabolic diseases
1987amylin.comSan Diego, United States
Develops cell-based assays and provides services for drug discovery and development.
2000discoverx.comBirmingham, United Kingdom
Premium access

Investor details for BioSeek

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BioSeek

3 dated milestones of BioSeek across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioSeek is founded.
  2. Funding First funding round of $10.0M.
  3. Exit Acquired by DiscoverX.

Competitors of BioSeek

BioSeek has 3 listed competitors in our database, 3 of them funded. They include Lucid Scientific, Kiyatec and CytoTronics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lucidsci.com2012Atlanta, United States$12.73M
Real-time cell analyzers are developed for oxygen consumption monitoring.
kiyatec.com2005Pendleton, United States$29.49M
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
cytotronics.com2015Boston, United States$22.75M22
Cell-based assays for drug discovery are developed via CMOS platform.
Premium access

Detailed competitors of BioSeek

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioSeek

Websites that share an audience with BioSeek (bioseekinc.com).

Similar websites

Websites whose visitors overlap most with BioSeek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
thresholdpharm.com
100%
View details
biopartners.ch
biopartners.ch
96%
–
proteus.fr
proteus.fr
96%
–
pepscan.nl
pepscan.nl
96%
–
ptcbio.com
96%
24.4K#1,154,739View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for BioSeek

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as BioSeek (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioseek

DiscoveRx Acquires BioSeek
Genengnews β€’ 14 years ago
Premium access

Complete news archive for BioSeek

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioSeek

BioSeek was founded in 2000 and raised its 1st funding round 7 years after it was founded.

BioSeek is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

BioSeek is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series C of $10M, raised on May 2007.

BioSeek was founded in 2000 in San Francisco, United States, as a provider of drug discovery services within the biotechnology sector. Human primary cell assays and predictive disease models are applied to support the development of therapeutics and chemicals. The BioMAP platform is utilized, encompassing BioMAP Systems with controlled human cell cultures, a BioMAP Database for reference profiles, and Predictive Analytics to guide development steps.

BioSeek's top competitors include CytoTronics, Kiyatec and Lucid Scientific.

BioSeek has 2 investors. Key investors include DiscoverX, and Amylin.

Yes. BioSeek was acquired by DiscoverX in October 2012.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available